InChIKey	XUBOMFCQGDBHNK-UHFFFAOYSA-N
Canonical SMILES	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Cross-Family
Avg pChEMBL	6.3
Source	ChEMBL;BindingDB

DrugBank ID	DB01044
Drug Name	Gatifloxacin
CAS Number	112811-59-3
Groups	approved investigational withdrawn
ATC Codes	S01AE06 J01MA16
Description	Gatifloxacin is an antibiotic agent and a member of the fourth-generation fluoroquinolone family. It works by inhibiting the bacterial enzymes DNA gyrase and topoisomerase IV. It was first introduced by Bristol-Myers Squibb in 1999 under the brand name Tequin® for the treatment of respiratory tract ...

---

Categories: 4-Quinolones Anti-Bacterial Agents Anti-Infective Agents Antibacterials for Systemic Use Antiinfectives for Systemic Use Compounds used in a research, industrial, or household setting Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (moderate) Cytochrome P-450 Enzyme Inhibitors Enzyme Inhibitors Fluoroquinolones Heterocyclic Compounds, Fused-Ring Hypoglycemia-Associated Agents Ophthalmic Solutions Ophthalmologicals Pharmaceutical Preparations Pharmaceutical Solutions Potential QTc-Prolonging Agents QTc Prolonging Agents Quinolines Quinolone Antimicrobial Quinolones Sensory Organs Solutions Topoisomerase II Inhibitors Topoisomerase Inhibitors

---

Cross-references: BindingDB: 50117914 ChEBI: 5280 CHEMBL31 ChemSpider: 5186 Drugs Product Database (DPD): 12056 C07661 D08011 PharmGKB: PA449738 PubChem:5379 PubChem:46506159 RxCUI: 1546025 Therapeutic Targets Database: DAP001387 Wikipedia: Gatifloxacin